« Return to News | Drug Sponsors | R&D Trends

Merck to cut jobs

Wednesday, April 13, 2011 01:16 PM

Merck is cutting production and staff at their Riverside, Pa. manufacturing plant.  The company plans to outsource some work and sell the plant's fermentation operations, according to Fierce Pharma.

Merck isn't shutting down the facility altogether. Instead, the company will focus its operations there on two antibiotics, Invanz and Primaxin, while bringing in a buyer to operate the fermentation line.  The company will outsource production of APIs for a cholesterol drug and an AIDS treatment. 

Some jobs will have to go, but Merck officials say they don't know how many. They also don't know when, spokeswoman Betse Humphrey said, because it will take time to outsource some of the production and to sell the fermentation operations. "The important thing is we are focusing on our antibiotic franchise," Humphrey said. "It's good news. We're looking at this as a way to remain in the community."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.